Variant report
Variant | nsv499101 |
---|---|
Chromosome Location | chr22:23244892-23263630 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:320)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:5)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ARID3A | chr22:23258750-23259076 | HepG2 | liver: | n/a | n/a |
2 | ATF1 | chr22:23253446-23253456 | K562 | blood: | n/a | n/a |
3 | ATF1 | chr22:23252055-23252437 | K562 | blood: | n/a | n/a |
4 | ATF1 | chr22:23246000-23246189 | K562 | blood: | n/a | n/a |
5 | ATF1 | chr22:23251232-23251667 | K562 | blood: | n/a | n/a |
6 | ATF1 | chr22:23262737-23263489 | K562 | blood: | n/a | n/a |
7 | ATF1 | chr22:23249632-23250275 | K562 | blood: | n/a | n/a |
8 | ATF1 | chr22:23254917-23254918 | K562 | blood: | n/a | n/a |
9 | ATF2 | chr22:23248892-23250514 | GM12878 | blood: | n/a | n/a |
10 | ATF2 | chr22:23243571-23245290 | GM12878 | blood: | n/a | n/a |
11 | ATF2 | chr22:23248930-23250295 | GM12878 | blood: | n/a | n/a |
12 | ATF2 | chr22:23245204-23245644 | GM12878 | blood: | n/a | n/a |
13 | ATF2 | chr22:23243556-23245167 | GM12878 | blood: | n/a | n/a |
14 | BACH1 | chr22:23259715-23259720 | K562 | blood: | n/a | n/a |
15 | BACH1 | chr22:23261304-23261342 | K562 | blood: | n/a | n/a |
16 | BATF | chr22:23248534-23248947 | GM12878 | blood: | n/a | n/a |
17 | BATF | chr22:23247193-23247431 | GM12878 | blood: | n/a | n/a |
18 | BCL11A | chr22:23248409-23248799 | GM12878 | blood: | n/a | n/a |
19 | BCL11A | chr22:23247624-23250417 | GM12878 | blood: | n/a | chr22:23248333-23248341 |
20 | BCL11A | chr22:23242268-23244947 | GM12878 | blood: | n/a | chr22:23242977-23242985 chr22:23243734-23243743 |
21 | BCL11A | chr22:23247178-23247521 | GM12878 | blood: | n/a | n/a |
22 | BCL3 | chr22:23248989-23250139 | GM12878 | blood: | n/a | n/a |
23 | BCL3 | chr22:23248947-23250094 | GM12878 | blood: | n/a | n/a |
24 | BCLAF1 | chr22:23248919-23250395 | GM12878 | blood: | n/a | n/a |
25 | BCLAF1 | chr22:23247264-23247668 | GM12878 | blood: | n/a | n/a |
26 | BCLAF1 | chr22:23248885-23250608 | GM12878 | blood: | n/a | n/a |
27 | BCLAF1 | chr22:23243527-23245345 | GM12878 | blood: | n/a | chr22:23243734-23243743 |
28 | BCLAF1 | chr22:23243562-23245335 | GM12878 | blood: | n/a | chr22:23243734-23243743 |
29 | BCLAF1 | chr22:23247293-23247606 | GM12878 | blood: | n/a | n/a |
30 | BHLHE40 | chr22:23263078-23263135 | K562 | blood: | n/a | n/a |
31 | BHLHE40 | chr22:23258770-23259136 | HepG2 | liver: | n/a | n/a |
32 | BHLHE40 | chr22:23249132-23249300 | GM12878 | blood: | n/a | n/a |
33 | BRCA1 | chr22:23244811-23244904 | HepG2 | liver: | n/a | n/a |
34 | BRCA1 | chr22:23256178-23256216 | GM12878 | blood: | n/a | n/a |
35 | CEBPB | chr22:23247129-23247730 | GM12878 | blood: | n/a | n/a |
36 | CEBPB | chr22:23248460-23250279 | GM12878 | blood: | n/a | n/a |
37 | CEBPB | chr22:23245763-23246032 | K562 | blood: | n/a | chr22:23245883-23245896 chr22:23245880-23245897 chr22:23245883-23245894 |
38 | CEBPB | chr22:23245712-23246025 | HepG2 | liver: | n/a | chr22:23245883-23245896 chr22:23245880-23245897 chr22:23245883-23245894 |
39 | CEBPB | chr22:23249424-23250035 | GM12878 | blood: | n/a | n/a |
40 | CEBPB | chr22:23242454-23244969 | GM12878 | blood: | n/a | chr22:23242713-23242730 chr22:23244530-23244547 |
41 | CHD2 | chr22:23256176-23256691 | GM12878 | blood: | n/a | n/a |
42 | CHD2 | chr22:23255821-23255822 | K562 | blood: | n/a | n/a |
43 | CHD2 | chr22:23261248-23261265 | K562 | blood: | n/a | n/a |
44 | CHD2 | chr22:23244751-23244945 | HepG2 | liver: | n/a | n/a |
45 | CHD2 | chr22:23243690-23245351 | GM12878 | blood: | n/a | n/a |
46 | CREB1 | chr22:23243597-23245289 | GM12878 | blood: | n/a | n/a |
47 | CREB1 | chr22:23248956-23250508 | GM12878 | blood: | n/a | n/a |
48 | CREB1 | chr22:23248947-23250720 | GM12878 | blood: | n/a | n/a |
49 | CREB1 | chr22:23243632-23244984 | GM12878 | blood: | n/a | n/a |
50 | CTCF | chr22:23247751-23247801 | GM10248 | blood: | n/a | n/a |
No data |
(count:17 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr22:23248970..23251030-chr22:23266059..23268328,2 | K562 | blood: | |
2 | chr22:23258107..23260177-chr22:23268082..23270661,2 | K562 | blood: | |
3 | chr22:23246871..23249530-chr22:23253643..23256082,2 | K562 | blood: | |
4 | chr22:23211923..23213773-chr22:23255638..23258101,2 | K562 | blood: | |
5 | chr22:23251853..23252558-chr22:23295506..23296354,3 | MCF-7 | breast: | |
6 | chr22:23234328..23239223-chr22:23249114..23253993,6 | K562 | blood: | |
7 | chr22:23237456..23241868-chr22:23242613..23249057,9 | K562 | blood: | |
8 | chr22:23249460..23256264-chr22:23263399..23267410,8 | K562 | blood: | |
9 | chr22:23261117..23263641-chr22:23264707..23267231,3 | K562 | blood: | |
10 | chr22:23236796..23239209-chr22:23258890..23261514,2 | K562 | blood: | |
11 | chr22:23249849..23250456-chr22:23284637..23285518,2 | K562 | blood: | |
12 | chr22:23230851..23232657-chr22:23258084..23260097,2 | K562 | blood: | |
13 | chr22:23249788..23251920-chr22:23270655..23273406,3 | K562 | blood: | |
14 | chr22:23245468..23247565-chr22:23249258..23251335,3 | K562 | blood: | |
15 | chr22:23249460..23256264-chr22:23263399..23267410,8 | K562 | blood: | |
16 | chr22:23237287..23240210-chr22:23254703..23257164,2 | K562 | blood: | |
17 | chr22:23152432..23153103-chr22:23254207..23254852,2 | K562 | blood: |
(count:5 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RTDR1-4 | chr22:23262147-23262154 | NONHSAT083834 |
2 | lnc-RTDR1-4 | chr22:23261700-23261973 | NONHSAT083834 |
3 | lnc-RTDR1-1 | chr22:23248506-23248831 | NONHSAT083775 |
4 | lnc-D87017.1-3 | chr22:23252998-23253245 | NONHSAT083835 |
5 | lnc-D87017.1-2 | chr22:23257805-23258097 | NONHSAT083836 |
No data |
No data |
Variant related genes | Relation type |
---|---|
IGLJ5 | TF binding region |
IGLC7 | TF binding region |
IGLJ7 | TF binding region |
IGLJ6 | TF binding region |
IGLJ4 | TF binding region |
IGLC4 | TF binding region |
IGLC5 | TF binding region |
IGLJ3 | TF binding region |
IGLC3 | TF binding region |
IGLC6 | TF binding region |
ENSG00000211675 | chromatin interactions |
ENSG00000211676 | chromatin interactions |
ENSG00000211685 | chromatin interactions |
ENSG00000254029 | chromatin interactions |
ENSG00000211684 | chromatin interactions |
ENSG00000211678 | chromatin interactions |
ENSG00000211674 | chromatin interactions |
ENSG00000211680 | chromatin interactions |
ENSG00000211679 | chromatin interactions |
ENSG00000211672 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574293278 | chr22:23244922-23244923 | Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
2 | rs552438222 | chr22:23244957-23244958 | Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
3 | rs117782184 | chr22:23244964-23244965 | Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
4 | rs537751140 | chr22:23244978-23244979 | Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
5 | rs554104126 | chr22:23244983-23244984 | Bivalent Enhancer Genic enhancers Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
6 | rs548920812 | chr22:23245039-23245040 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
7 | rs574110414 | chr22:23245040-23245041 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
8 | rs533853661 | chr22:23245098-23245099 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
9 | rs457529 | chr22:23245173-23245174 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
10 | rs573368874 | chr22:23245174-23245175 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
11 | rs545315703 | chr22:23245194-23245195 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
12 | rs73164962 | chr22:23245195-23245196 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
13 | rs552173364 | chr22:23245204-23245205 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
14 | rs139436244 | chr22:23245229-23245230 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
15 | rs2859790 | chr22:23245236-23245237 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
16 | rs531304764 | chr22:23245248-23245249 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
17 | rs561240667 | chr22:23245356-23245357 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
18 | rs530069236 | chr22:23245387-23245388 | Genic enhancers Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
19 | rs547056070 | chr22:23245407-23245408 | Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
20 | rs560423843 | chr22:23245469-23245470 | Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
21 | rs2001032 | chr22:23245506-23245507 | Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
22 | rs11912742 | chr22:23245588-23245589 | Flanking Active TSS Enhancers Weak transcription Bivalent Enhancer Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
23 | rs149641990 | chr22:23245611-23245612 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
24 | rs375674619 | chr22:23245625-23245626 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
25 | rs568719101 | chr22:23245655-23245656 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
26 | rs548309869 | chr22:23245657-23245658 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
27 | rs115959970 | chr22:23245676-23245677 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
28 | rs567694693 | chr22:23245738-23245739 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
29 | rs144209011 | chr22:23245751-23245752 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
30 | rs553819302 | chr22:23245761-23245762 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
31 | rs386820017 | chr22:23245773-23245774 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
32 | rs576819286 | chr22:23245774-23245775 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
33 | rs372949363 | chr22:23245791-23245792 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
34 | rs575934670 | chr22:23245829-23245830 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
35 | rs544898873 | chr22:23245836-23245837 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
36 | rs561601916 | chr22:23245879-23245880 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
37 | rs544575220 | chr22:23245921-23245922 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
38 | rs574767800 | chr22:23245932-23245933 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
39 | rs2854092 | chr22:23245943-23245944 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
40 | rs560540568 | chr22:23245972-23245973 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
41 | rs532458914 | chr22:23245978-23245979 | Flanking Active TSS Enhancers Bivalent Enhancer Strong transcription Weak transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
42 | rs552268056 | chr22:23246011-23246012 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
43 | rs184219255 | chr22:23246014-23246015 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
44 | rs188825742 | chr22:23246015-23246016 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
45 | rs370343715 | chr22:23246038-23246039 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
46 | rs548062229 | chr22:23246046-23246047 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
47 | rs568302185 | chr22:23246077-23246078 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
48 | rs527273822 | chr22:23246085-23246086 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
49 | rs547039427 | chr22:23246123-23246124 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
50 | rs548019158 | chr22:23246157-23246158 | Flanking Active TSS Enhancers Weak transcription Strong transcription | TF binding regionChromatin interactive region | 4 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Velocardiofacial syndrome | 20111667 | CNVD |
Medulloblastoma | 21979893 | CNVD |
sporadic solitary meningiomas | 19589153 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Autism | 22495311 | CNVD |
Emanuel syndrome | 21549014 | CNVD |
Digeorge syndrome | 22283845 | CNVD |
Schizophrenia | 17504246 | CNVD |
Digeorge syndrome | 18033723 | CNVD |
22q11 deletion syndrome | 17034021 | CNVD |
22q11 deletion syndrome | 22511897 | CNVD |
22q11 deletion syndrome | 16829213 | CNVD |
Autism | 22067053 | CNVD |
Autism | 19218893 | CNVD |
Biliary cancer | 22067053 | CNVD |
Congenital heart defect | 21390462 | CNVD |
Digeorge syndrome | 16617304 | CNVD |
Emanuel syndrome | 18184694 | CNVD |
Non-syndromic sensorineural hearing loss | 18184694 | CNVD |
Obsessive-compulsive disorder | 22067053 | CNVD |
Psychosis | 22067053 | CNVD |
Schizophrenia | 19415332 | CNVD |
Schizophrenia | 20587603 | CNVD |
Shprintzen syndrome | 19443537 | CNVD |
absent pulmonary valve syndrome | 16795129 | CNVD |
language delay | 22067053 | CNVD |
periventricular nodular heterotopia | 20648244 | CNVD |
renal disease | 17924346 | CNVD |
Schizophrenia | 20433910 | CNVD |
22q11 deletion syndrome | 17028864 | CNVD |
Schizophrenia | 16969581 | CNVD |
Non-syndromic sensorineural hearing loss | 17135275 | CNVD |
velo-cardio-facial syndrome | 17135275 | CNVD |
Digeorge syndrome | 18787571 | CNVD |
Autism | 18925931 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
22q11.2 microdeletion syndrome | 21547621 | CNVD |
Congenital heart defect | 21308838 | CNVD |
Digeorge syndrome | 16512914 | CNVD |
Digeorge syndrome | 20954168 | CNVD |
Nuchal translucency | 21837766 | CNVD |
Right aortic arch in the fetus | 17066500 | CNVD |
Shprintzen syndrome | 17117043 | CNVD |
Tetralogy of fallot | 17405110 | CNVD |
Velocardiofacial syndrome | 20140301 | CNVD |
Velocardiofacial syndrome | 16512914 | CNVD |
bone mass and metabolism | 20516202 | CNVD |
choanal atresia | 18209138 | CNVD |
extracardiac malformations | 17086578 | CNVD |
fetal heart defects | 21308838 | CNVD |
parathyroid gland dysfunction | 16793949 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
velopharyngeal insufficiency | 19620585 | CNVD |
Prader-willi syndrome | 20942916 | CNVD |
22q11 deletion syndrome | 17653112 | CNVD |
Chronic myelomonocytic leukemia | 16760666 | CNVD |
Non-syndromic sensorineural hearing loss | 16829213 | CNVD |
Non-syndromic sensorineural hearing loss | 16760666 | CNVD |
Chordoma | 21602918 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Congenital heart defect | 22511896 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Seminomas | 18059402 | CNVD |
Cancer | 16751803 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Metachromatic leukodystrophy | 18421352 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Breast cancer | 21858162 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cat eye syndrome | 21549014 | CNVD |
Digeorge syndrome | 21549014 | CNVD |
22q11.2 microdeletion syndrome | 22051516 | CNVD |
22q11.2 microdeletion syndrome | 18483005 | CNVD |
22q11.2 microdeletion syndrome | 19565140 | CNVD |
22q11.2 microdeletion syndrome | 20396437 | CNVD |
22q11.2 microdeletion syndrome | 21390462 | CNVD |
22q11.2 microdeletion syndrome | 21573985 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 20970697 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Congenital heart defect | 21257016 | CNVD |
Developmental delay | 18414209 | CNVD |
DiGeorge-Velo cardiofacial | 19284877 | CNVD |
Epilepsy | 20970697 | CNVD |
Heart disease | 20551144 | CNVD |
Hughes'' syndrome | 16595601 | CNVD |
Mental retardation | 18414209 | CNVD |
Okamoto syndrome | 19046188 | CNVD |
Primary immunodeficiency | 22566803 | CNVD |
Schizophrenia | 20877625 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 21956041 | CNVD |
Schizophrenia | 20970697 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Velocardiofacial syndrome | 17556857 | CNVD |
Velocardiofacial syndrome | 20206275 | CNVD |
Velocardiofacial syndrome | 20970697 | CNVD |
delayed speech development | 21274400 | CNVD |
velo-cardio-facial syndrome | 16511839 | CNVD |
velo-cardio-facial syndrome | 21763005 | CNVD |
22q11.2 microdeletion syndrome | 18799940 | CNVD |
Digeorge syndrome | 20877625 | CNVD |
22q11.2 microdeletion syndrome | 18923514 | CNVD |
Congenital heart defect | 22185286 | CNVD |
DiGeorge-Velo cardiofacial | 16773131 | CNVD |
Digeorge syndrome | 20186050 | CNVD |
velo-cardio-facial conotruncal-face syndrome | 20186050 | CNVD |
22q11.2 microdeletion syndrome | 22116936 | CNVD |
Disorders of sex development | 22290220 | CNVD |
22q11.2 duplication syndrome | 18923514 | CNVD |
Autism | 22095694 | CNVD |
Mental retardation | 19951919 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Mental retardation | 16773131 | CNVD |
22q11.2 microdeletion syndrome | 22395003 | CNVD |
22q11.2 microdeletion syndrome | 18691436 | CNVD |
22q11.2 microdeletion syndrome | 18053182 | CNVD |
22q11.2 microdeletion syndrome | 18324686 | CNVD |
22q11.2 microdeletion syndrome | 20074913 | CNVD |
Congenital heart defect | 20802965 | CNVD |
Congenital heart defect | 21134246 | CNVD |
DiGeorge syndrome | 19040613 | CNVD |
DiGeorge-Velo cardiofacial | 18179902 | CNVD |
Digeorge syndrome | 18172682 | CNVD |
Digeorge syndrome | 22470819 | CNVD |
Digeorge syndrome | 21364285 | CNVD |
Neuroendocrine carcinoma | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20069674 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Tetralogy of fallot | 19144126 | CNVD |
Velo-cardio-facial syndrome | 21364285 | CNVD |
Velocardiofacial syndrome | 18788013 | CNVD |
cardiac malformation | 20573211 | CNVD |
cardiac malformation | 18172682 | CNVD |
velo-cardio-facial syndrome | 18636631 | CNVD |
Schizophrenia | 21822266 | CNVD |
synaptic plasticity | 21368174 | CNVD |
Schizophrenia | 18043741 | CNVD |
sporadic birth defects | 19047251 | CNVD |
Autism | 19046189 | CNVD |
DiGeorge-Velo cardiofacial | 19047251 | CNVD |
Hypernasal speech | 21968682 | CNVD |
Mental retardation | 17339581 | CNVD |
diverse phenotype | 16760730 | CNVD |
Mental retardation | 20152051 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Ovarian cancer | 22174824 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
DiGeorge-Velo cardiofacial | 17597781 | CNVD |
Digeorge syndrome | 17576883 | CNVD |
Schizophrenia | 18806272 | CNVD |
Schizophrenia | 18990708 | CNVD |
Velocardiofacial syndrome | 17576883 | CNVD |
Schizophrenia | 20075378 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Neuropsychiatric disorder | 20069037 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Emphysema | 19352772 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Disease | 21346257 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Developmental delay | 21147756 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Asthma | 21956041 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Systemic lupus erythematosus | 21956041 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
22q11.23 microdeletion syndrome | 19193630 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Autism | 20841430 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Medullary thyroid carcinoma | 18765511 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ependymoma | 20639864 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
Schizophrenia | 17989066 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr22:23237800-23245600 | Weak transcription | Primary mononuclear cells fromperipheralblood | Blood |
2 | chr22:23243800-23245000 | Bivalent Enhancer | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr22:23243800-23245000 | Bivalent Enhancer | Rectal Mucosa Donor 31 | rectum |
4 | chr22:23243800-23245800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
5 | chr22:23243800-23245800 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
6 | chr22:23243800-23246000 | Enhancers | HSMMtube | muscle |
7 | chr22:23243800-23247400 | Strong transcription | Right Atrium | heart |
8 | chr22:23243800-23247600 | Enhancers | Dnd41 | blood |
9 | chr22:23244000-23245000 | Bivalent Enhancer | Small Intestine | intestine |
10 | chr22:23244000-23245000 | Enhancers | Stomach Smooth Muscle | stomach |
11 | chr22:23244200-23245200 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
12 | chr22:23244400-23246000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
13 | chr22:23244400-23246000 | Enhancers | Fetal Lung | lung |
14 | chr22:23244600-23246000 | Enhancers | Fetal Stomach | stomach |
15 | chr22:23244600-23246000 | Enhancers | HSMM | muscle |
16 | chr22:23244600-23247000 | Enhancers | GM12878-XiMat | blood |
17 | chr22:23244800-23245200 | Enhancers | Sigmoid Colon | Sigmoid Colon |
18 | chr22:23244800-23245400 | Genic enhancers | Primary B cells from cord blood | blood |
19 | chr22:23244800-23245400 | Genic enhancers | Primary B cells from peripheral blood | blood |
20 | chr22:23245000-23246800 | Weak transcription | Stomach Smooth Muscle | stomach |
21 | chr22:23245400-23246000 | Enhancers | Monocytes-CD14+_RO01746 | blood |
22 | chr22:23245400-23246800 | Enhancers | Primary B cells from peripheral blood | blood |
23 | chr22:23245400-23247200 | Flanking Active TSS | Primary B cells from cord blood | blood |
24 | chr22:23245600-23245800 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
25 | chr22:23245600-23246000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
26 | chr22:23245800-23246000 | Bivalent Enhancer | Muscle Satellite Cultured Cells | -- |
27 | chr22:23245800-23246000 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
28 | chr22:23245800-23247200 | Enhancers | Fetal Muscle Trunk | muscle |
29 | chr22:23245800-23247400 | Enhancers | Fetal Muscle Leg | muscle |
30 | chr22:23246000-23246800 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
31 | chr22:23246000-23246800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
32 | chr22:23246800-23247000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
33 | chr22:23246800-23247000 | Enhancers | Stomach Smooth Muscle | stomach |
34 | chr22:23246800-23247200 | Flanking Active TSS | Primary B cells from peripheral blood | blood |
35 | chr22:23247000-23249000 | Weak transcription | GM12878-XiMat | blood |
36 | chr22:23247200-23247600 | Active TSS | Primary B cells from cord blood | blood |
37 | chr22:23247200-23247800 | Active TSS | Primary B cells from peripheral blood | blood |
38 | chr22:23247400-23249800 | Weak transcription | Right Atrium | heart |
39 | chr22:23247600-23249000 | Weak transcription | Primary B cells from cord blood | blood |
40 | chr22:23247600-23251800 | Weak transcription | Dnd41 | blood |
41 | chr22:23247800-23249000 | Weak transcription | Primary B cells from peripheral blood | blood |
42 | chr22:23249000-23249400 | Flanking Active TSS | Primary B cells from cord blood | blood |
43 | chr22:23249000-23249400 | Flanking Active TSS | GM12878-XiMat | blood |
44 | chr22:23249000-23249600 | Transcr. at gene 5' and 3' | Primary B cells from peripheral blood | blood |
45 | chr22:23249400-23249600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
46 | chr22:23249400-23249800 | Genic enhancers | Primary B cells from cord blood | blood |
47 | chr22:23249400-23250800 | Enhancers | GM12878-XiMat | blood |
48 | chr22:23249600-23249800 | Genic enhancers | Primary B cells from peripheral blood | blood |
49 | chr22:23249800-23250600 | Enhancers | Primary B cells from cord blood | blood |
50 | chr22:23249800-23258400 | Enhancers | Primary B cells from peripheral blood | blood |